65 i b, drugs, pharmaceuticals, & hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79723D0126
- Awardee
-
Glaukos Corporation UEI M77LMBPAZLL9
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 6
Award facts
- Opportunity
-
- 651B Solicitation number
- Last date to order 68% complete
- IDV ceiling
- $584,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Glaukos Corporation under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on June 1, 2023, with a $584,000.00 ceiling and performance extending through May 31, 2028. The schedule covers Drugs, Pharmaceuticals, & Hematology Related Products with a single award to this contractor, supporting ordering by Veterans Integrated Service Networks across the Department of Veterans Affairs.
Performance occurs at Waltham, Massachusetts. The contract operates as a multi-agency indefinite delivery vehicle, enabling VA regional networks to issue delivery orders and blanket purchase agreements against the established price list without competitive re-competition.
Recent ordering activity under this schedule includes four delivery orders awarded to Avedro, Inc., Glaukos Corporation's subsidiary: $213,105.60 for IDOSE TRAVOPROST 75MCG IMPLANT (VISN 15, awarded July 10, 2024); $95,897.52 for IDOSE TR 75CMG IMPLANT (VISN 12, awarded June 15, 2024); $169,104.64 for Travoprost 75 micrograms (VISN 12, awarded February 1, 2026); and $10,655.28 for IDOSE TR 75 MGC IMPLANT (VISN 5, awarded August 12, 2025). A blanket purchase agreement valued at $106,552.80 for IDOSE TRAVOPROST 75MCG IMPLANT was awarded February 1, 2025, with performance extending through January 31, 2030. All ordering activity carries firm fixed-price structures with no set-aside designations. The portfolio reflects Glaukos Corporation's specialization in advanced ophthalmic medical devices and pharmaceutical solutions for glaucoma and ocular hypertension treatment within the VA healthcare procurement ecosystem.
Task orders
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36C25525A0003 | Veterans Integrated Service Network 15 (VHA) | $106,553 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 15
Quick answers
Who was awarded contract 36F79723D0126?
36F79723D0126 was awarded to Glaukos Corporation by Veterans Integrated Service Network 12 (Veterans Health Administration) on June 1, 2023.
How much is contract 36F79723D0126 worth?
36F79723D0126's own ceiling is $584,000.
How many orders have been placed under contract 36F79723D0126?
6 orders have been placed under 36F79723D0126, the latest on February 1, 2026.
Who can order from contract 36F79723D0126?
36F79723D0126 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79723D0126 part of a contract vehicle?
Yes. 36F79723D0126 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79723D0126 competed?
The extent of competition for 36F79723D0126 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV